EpiCept Corporation Receives One-Month Extension to Loan and Security Agreement
19 oct. 2012 00h01 HE
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced
today that MidCap Financial, LLC...
EpiCept Corporation Raises $0.8 Million from Immediate Exercise of Re-priced Warrants
25 sept. 2012 00h26 HE
|
Immune Pharmaceuticals Inc
Series A and B Preferred Stock Conversion Prices Also Affected
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange...
EpiCept Regains Rights to Azixa® from Licensee Myrexis
05 sept. 2012 00h01 HE
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced
today it has received notice of...
EpiCept Amends Loan and Security Agreement
31 août 2012 00h01 HE
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced
today that it has amended the...
EpiCept Announces Changes to Its Board of Directors
30 août 2012 00h01 HE
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced
today that A. Collier Smyth, Gerhard...
EpiCept Announces Resignation of CEO Jack Talley
21 août 2012 17h45 HE
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced
today that Jack Talley has resigned as...
EpiCept Reports Second Quarter 2012 Operating and Financial Results
08 août 2012 00h02 HE
|
Immune Pharmaceuticals Inc
CONFERENCE CALL BEGINS AT 9:00 A.M. EASTERN TIME TODAY
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX:...
EpiCept to Report Second Quarter 2012 Operating and Financial Results on August 8, 2012
02 août 2012 17h00 HE
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced
today that it will host a conference...
EpiCept Transfers Ceplene Responsibilities in European Union and Sells License Rights to Meda
19 juin 2012 00h02 HE
|
Immune Pharmaceuticals Inc
ONLY TERRITORY ALREADY LICENSED TO MEDA AFFECTED
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)...
EpiCept Corporation to Present at 2012 BIO International Convention
12 juin 2012 17h01 HE
|
Immune Pharmaceuticals Inc
2012 BIO International Convention
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)...